Publications by authors named "Robert Simko"

Claim this Profile
C
Correction: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study.
Javier Díez-Domingo, Róbert Simkó, Giancarlo Icardi, Chan Poh Chong, Céline Zocchetti

Infect Dis Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Immune Persistence of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) and Immunogenicity and Safety of a Booster Dose in Children.
Federico Martinón-Torres, Robert Simko, Rolf Ebert, Mika Rämet, Céline Zocchetti

Infect Dis Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study.
Javier Díez-Domingo, Róbert Simkó, Giancarlo Icardi, Chan Poh Chong, Céline Zocchetti

Infect Dis Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody persistence and booster responses 24-36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial.
Federico Martinón-Torres, Alfonso Carmona Martinez, Róbert Simkó, Pilar Infante Marquez, Josep-Lluis Arimany

J Infect· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Varicella vaccine without human serum albumin versus licensed varicella vaccine in children during the second year of life: a randomized, double-blind, non-inferiority trial.
Roman Prymula, Robert Simko, Michael Povey, Andrea Kulcsar

BMC Pediatr· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
Peter P Toth, Robert J Simko, Swetha Rao Palli, Dawn Koselleck, Ralph A Quimbo

Cardiovasc Diabetol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an interactive model of the burden of future coronary heart disease from an employer perspective.
Kathleen Lang, Jonathan R Korn, Robert J Simko, Woodie M Zachry, Nikil V Patel

J Occup Environ Med· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence.
Sanjeev Balu, Robert J Simko, Ralph M Quimbo, Mark J Cziraky

Curr Med Res Opin· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attainment of combined optimal lipid values and the impact of lipid medication on cardiovascular outcomes and costs in a commercially insured population in the US.
Ralph A Quimbo, Robert J Simko, Mark J Cziraky, Russel T Burge

J Med Econ· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sonja V Sorensen, Kevin D Frick, Alexander Wade, Robert Simko, Russel Burge

Clin Ther· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis